Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Prophylactic Tranexamic Acid on Perioperative Blood Loss in High-Risk Cesarean Delivery
NCT07870499Completed
- Start
- Jan 2022
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (4 arms). Primary endpoint: Estimated Blood Loss at 4 hours. Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07870499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07870499.